Patents by Inventor Daniel Gil

Daniel Gil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230322765
    Abstract: The present disclosure relates to novel compounds that are capable of inhibiting the mitochondrial pyruvate carrier and promoting hair growth. The disclosure further relates to methods of promoting hair growth or treating conditions or disorders affecting hair growth, such as baldness or alopecia.
    Type: Application
    Filed: June 29, 2021
    Publication date: October 12, 2023
    Inventors: Daniel L. Sun, Michael E. Jung, Daniel Gil
  • Patent number: 11638836
    Abstract: A sterilization system uses ultraviolet radiation and ozone to eradicate deadly pathogens to sterilize a surface of an object or wound/incision site at an adjustable intensity level. The sterilization system has ultraviolet emitters that emit ultraviolet light in wavelengths that kill pathogens and in wavelengths that produce ozone at the sites, therefore killing/disabling several hard-to-kill pathogens. The sterilization system has an intensity control and proximity detectors to enable ultraviolet emission only when the system is properly located near or against the surface so as to protect from unwanted radiation from the ultraviolet light.
    Type: Grant
    Filed: February 13, 2020
    Date of Patent: May 2, 2023
    Assignee: HEPCO Holdings, LLC
    Inventors: Patricia Carol Gil, Asher Gil, Daniel Gil
  • Publication number: 20220273557
    Abstract: The present invention is related to topical ophthalmic compositions comprising brimonidine. Also described herein are methods for the treatment of ocular conditions (e.g., presbyopia), methods for improving near reading speed in a subject with presbyopia, methods for improving near vision in a subject with presbyopia, and methods for reducing pupil diameter in a subject with presbyopia using the topical ophthalmic compositions.
    Type: Application
    Filed: July 24, 2020
    Publication date: September 1, 2022
    Inventors: Mohammed Dibas, Daniel Gil, Arthur Bradley, Renfeng Xu
  • Publication number: 20200179718
    Abstract: A sterilization system uses ultraviolet radiation and ozone to eradicate deadly pathogens to sterilize a surface of an object or wound/incision site at an adjustable intensity level. The sterilization system has ultraviolet emitters that emit ultraviolet light in wavelengths that kill pathogens and in wavelengths that produce ozone at the sites, therefore killing/disabling several hard-to-kill pathogens. The sterilization system has an intensity control and proximity detectors to enable ultraviolet emission only when the system is properly located near or against the surface so as to protect from unwanted radiation from the ultraviolet light.
    Type: Application
    Filed: February 13, 2020
    Publication date: June 11, 2020
    Applicant: HEPCO HOLDINGS, LLC
    Inventors: Patricia Carol Gil, Asher Gil, Daniel Gil
  • Patent number: 10596282
    Abstract: A sterilization system uses ultraviolet radiation and ozone to eradicate deadly pathogens to sterilize a zone of a surface of an object or wound/incision sites. The sterilization system offers a safe sterilization method prior to or after surgery and/or closure wounds/incisions. The sterilization system has ultraviolet emitters that emit ultraviolet light in wavelengths that kill pathogens and in wavelengths that produce ozone at the sites, therefore killing/disabling several hard-to-kill pathogens. The sterilization system has proximity detectors to enable ultraviolet emission only when the system is properly located near or against the surface so as to protect from unwanted radiation from the ultraviolet light.
    Type: Grant
    Filed: May 11, 2019
    Date of Patent: March 24, 2020
    Assignee: Hepco Holdings, LLC
    Inventors: Patricia Carol Gil, Asher Gil, Daniel Gil
  • Publication number: 20190262487
    Abstract: A sterilization system uses ultraviolet radiation and ozone to eradicate deadly pathogens to sterilize a zone of a surface of an object or wound/incision sites. The sterilization system offers a safe sterilization method prior to or after surgery and/or closure wounds/incisions. The sterilization system has ultraviolet emitters that emit ultraviolet light in wavelengths that kill pathogens and in wavelengths that produce ozone at the sites, therefore killing/disabling several hard-to-kill pathogens. The sterilization system has proximity detectors to enable ultraviolet emission only when the system is properly located near or against the surface so as to protect from unwanted radiation from the ultraviolet light.
    Type: Application
    Filed: May 11, 2019
    Publication date: August 29, 2019
    Applicant: HEPCO HOLDINGS, LLC
    Inventors: Patricia Carol Gil, Asher Gil, Daniel Gil
  • Patent number: 10335505
    Abstract: A sterilization system uses ultraviolet radiation and ozone to eradicate deadly pathogens to sterilize wound/incision sites. The sterilization system offers a safe sterilization method prior to or after surgery and/or closure wounds/incisions. The sterilization system has ultraviolet emitters that emit ultraviolet light in wavelengths that kill pathogens and in wavelengths that produce ozone at the sites, therefore killing/disabling several hard-to-kill pathogens. The sterilization system has surface detectors to enable ultraviolet emission only when the system is properly seated against the skin so as to protect from unwanted radiation from the ultraviolet light.
    Type: Grant
    Filed: August 23, 2017
    Date of Patent: July 2, 2019
    Assignee: Hepco Holdings, LLC
    Inventors: Patricia Carol Gil, Asher Gil, Daniel Gil
  • Publication number: 20190060495
    Abstract: A sterilization system uses ultraviolet radiation and ozone to eradicate deadly pathogens to sterilize wound/incision sites. The sterilization system offers a safe sterilization method prior to or after surgery and/or closure wounds/incisions. The sterilization system has ultraviolet emitters that emit ultraviolet light in wavelengths that kill pathogens and in wavelengths that produce ozone at the sites, therefore killing/disabling several hard-to-kill pathogens. The sterilization system has surface detectors to enable ultraviolet emission only when the system is properly seated against the skin so as to protect from unwanted radiation from the ultraviolet light.
    Type: Application
    Filed: August 23, 2017
    Publication date: February 28, 2019
    Applicant: HEPCO HOLDINGS, LLC
    Inventors: Patricia Carol Gil, Asher Gil, Daniel Gil
  • Patent number: 10017419
    Abstract: Composite fibers and methods of manufacturing composite fibers for the reinforcement of concrete are provided. The composite fibers include fibers and a polymeric coating. The composite fibers have a length of about 10 mm to about 80 mm and an equivalent diameter from about 0.3 mm to about 2 mm. A method for reinforcing concrete using the composite fibers is further provided.
    Type: Grant
    Filed: May 23, 2017
    Date of Patent: July 10, 2018
    Assignee: OCV Intellectual Capital, LLC
    Inventors: Gerard Tardy, David Blandin, Daniel Gil, Benoit Lorre, Olivier Laurence, Bryan Barragan
  • Publication number: 20180125951
    Abstract: Methods for treating, reducing the occurrence or preventing a histamine-independent pruritic itch using a clostridial toxin derivative are provided herein. In some aspects, the clostridial toxin derivative reduces the itch intensity or duration without affecting thermal or pain sensitivity.
    Type: Application
    Filed: November 9, 2017
    Publication date: May 10, 2018
    Inventors: Edward Hsia, Daniel Gil
  • Publication number: 20170253527
    Abstract: Composite fibers and methods of manufacturing composite fibers for the reinforcement of concrete are provided. The composite fibers include fibers and a polymeric coating. The composite fibers have a length of about 10 mm to about 80 mm and an equivalent diameter from about 0.3 mm to about 2 mm. A method for reinforcing concrete using the composite fibers is further provided.
    Type: Application
    Filed: May 23, 2017
    Publication date: September 7, 2017
    Inventors: Gerard Tardy, David Blandin, Daniel Gil, Benoit Lorre, Olivier Laurence, Bryan Barragan
  • Publication number: 20160194246
    Abstract: Composite fibers and methods of manufacturing composite fibers for the reinforcement of concrete are provided. The composite fibers include fibers and a polymeric coating. The composite fibers have a length of about 10 to about 80 mm and an equivalent diameter from about 0.3 to about 2 mm. A method for reinforcing concrete using the composite fibers is further provided.
    Type: Application
    Filed: September 2, 2014
    Publication date: July 7, 2016
    Inventors: Gerard TARDY, David BLANDIN, Daniel GIL, Benoit LORRE, Olivier LAURENCE, Bryan BARRAGAN
  • Publication number: 20160101202
    Abstract: An object sterilization system includes an enclosure having an access door with at least one ultraviolet emitting device supported within the enclosure. The ultraviolet emitting device(s) are for directing ultraviolet radiation on an object placed within the enclosure. A source of power is interfaced to each of the at least one ultraviolet emitting devices, operatively flowing current through each of the at least one ultraviolet emitting devices, thereby each of the at least one ultraviolet emitting device emits ultraviolet radiation for producing ozone and for sterilizing the object.
    Type: Application
    Filed: October 1, 2015
    Publication date: April 14, 2016
    Applicant: HEPCO MEDICAL, LLC
    Inventors: Patricia Carol Gil, Asher Gil, Daniel Gil
  • Publication number: 20150166830
    Abstract: The present invention relates to, a sizing composition for reinforcing glass fiber strands, which comprises a silane coupling agent, a polyurethane film-forming agent including a blocked isocyanate and water. The invention also relates to glass fiber strands onto which the sizing composition has been applied, and to concrete reinforced with said glass fiber strands.
    Type: Application
    Filed: September 23, 2011
    Publication date: June 18, 2015
    Applicant: OCV Intellectual Capital, LLC
    Inventors: Gerard Tardy, Daniel Gil, Julie Mazzi, Leticia Antepazo, Mariano Rico Martinez, Jese Antonio Foncubierta Arias
  • Patent number: 8784731
    Abstract: A foot/shoe sanitizing system includes a housing having at least one opening and at least one ultraviolet emitting device supported within the housing. The ultraviolet emitting devices direct ultraviolet light around and/or through the set of foot/shoe support bars towards the foot or shoe placed on the foot/shoe support bars. The ultraviolet emitting devices are controllably powered to emit ultraviolet light and/or ozone onto the foot/shoe. In a preferred embodiment, the ultraviolet emitting device emits light that includes short wavelength ultraviolet light, causing the formation of ozone in the area of the shoe, thereby killing pathogens that are not easily killed with ultraviolet light alone. The system includes a sheet of activated carbon for catalyzing the ozone into harmless concentrations of carbon monoxide and carbon dioxide.
    Type: Grant
    Filed: February 24, 2014
    Date of Patent: July 22, 2014
    Assignee: Hepco Medical, LLC
    Inventors: Patricia Carol Gil, Asher Gil, Daniel Gil, Norman D. Knoth
  • Publication number: 20140170019
    Abstract: A foot/shoe sanitizing system includes a housing having at least one opening and at least one ultraviolet emitting device supported within the housing. The ultraviolet emitting devices direct ultraviolet light around and/or through the set of foot/shoe support bars towards the foot or shoe placed on the foot/shoe support bars. The ultraviolet emitting devices are controllably powered to emit ultraviolet light and/or ozone onto the foot/shoe. In a preferred embodiment, the ultraviolet emitting device emits light that includes short wavelength ultraviolet light, causing the formation of ozone in the area of the shoe, thereby killing pathogens that are not easily killed with ultraviolet light alone. The system includes a sheet of activated carbon for catalyzing the ozone into harmless concentrations of carbon monoxide and carbon dioxide.
    Type: Application
    Filed: February 24, 2014
    Publication date: June 19, 2014
    Applicant: HEPCO MEDICAL, LLC
    Inventors: Patricia Carol Gil, Asher Gil, Daniel Gil, Norman D. Knoth
  • Patent number: 8696985
    Abstract: A foot/shoe sanitizing system includes a housing having at least one opening and at least one ultraviolet emitting device supported within the housing. The ultraviolet emitting devices direct ultraviolet light around and/or through the set of foot/shoe support bars towards the foot or shoe placed on the foot/shoe support bars. The ultraviolet emitting devices are controllably powered to emit ultraviolet light and/or ozone onto the foot/shoe. In a preferred embodiment, the ultraviolet emitting device emits light that includes short wavelength ultraviolet light, causing the formation of ozone in the area of the shoe, thereby killing pathogens that are not easily killed with ultraviolet light alone. The system detects the identity of a user and records/transmits usage of the system by the user for sanitizing enforcement and recording.
    Type: Grant
    Filed: August 20, 2013
    Date of Patent: April 15, 2014
    Assignee: Hepco Medical, LLC
    Inventors: Patricia Carol Gil, Asher Gil, Daniel Gil, Norman D. Knoth
  • Patent number: 8617479
    Abstract: A foot/shoe sanitizing system includes a housing having at least one opening and a set of foot/shoe support bars coupled to the housing in proximity to the at least one opening. The foot/shoe support bars support a foot or shoe placed through the opening(s). At least one ultraviolet emitting device is supported within the housing beneath the set of foot/shoe support bars. The ultraviolet emitting devices direct ultraviolet light around and/or through the set of foot/shoe support bars towards the foot or shoe placed on the foot/shoe support bars. The ultraviolet emitting devices are controllably powered by a source of power to emit ultraviolet light. In a preferred embodiment, the ultraviolet emitting device emits light that includes short wavelength ultraviolet light, causing the formation of ozone in the area of the shoe, thereby killing pathogens that are not easily killed with ultraviolet light alone.
    Type: Grant
    Filed: December 10, 2012
    Date of Patent: December 31, 2013
    Assignee: Hepco Medical, LLC
    Inventors: Patricia Carol Gil, Asher Gil, Daniel Gil, Norman D. Knoth
  • Publication number: 20130336839
    Abstract: A foot/shoe sanitizing system includes a housing having at least one opening and at least one ultraviolet emitting device supported within the housing. The ultraviolet emitting devices direct ultraviolet light around and/or through the set of foot/shoe support bars towards the foot or shoe placed on the foot/shoe support bars. The ultraviolet emitting devices are controllably powered to emit ultraviolet light and/or ozone onto the foot/shoe. In a preferred embodiment, the ultraviolet emitting device emits light that includes short wavelength ultraviolet light, causing the formation of ozone in the area of the shoe, thereby killing pathogens that are not easily killed with ultraviolet light alone. The system detects the identity of a user and records/transmits usage of the system by the user for sanitizing enforcement and recording.
    Type: Application
    Filed: August 20, 2013
    Publication date: December 19, 2013
    Applicant: HEPCO MEDICAL, LLC
    Inventors: Patricia Carol Gil, Asher Gil, Daniel Gil, Norman D. Knoth
  • Patent number: 8071635
    Abstract: Compounds of Formula 1 where X is S and the variables have the meaning defined in the specification are specific or selective to alpha2B and/or alpha2C adrenergic receptors in preference over alpha2A adrenergic receptors, and as such have no or only minimal cardiovascular and/or sedatory activity. These compounds of Formula 1 are useful as medicaments in mammals, including humans, for treatment of diseases and or alleviations of conditions which are responsive to treatment by agonists of alpha2B adrenergic receptors. Compounds of Formula 1 where X is O also have the advantageous property that they have no or only minimal cardiovascular and/or sedatory activity and are useful for treating pain and other conditions with no or only minimal cardiovascular and/or sedatory activity.
    Type: Grant
    Filed: February 16, 2008
    Date of Patent: December 6, 2011
    Assignee: Allergan, Inc.
    Inventors: Ken Chow, Todd Heidelbaugh, Daniel Gil, Michael Garst, Larry A. Wheeler, Phong X. Nguyen, Dario G. Gomez